Lumos Pharma
(NASDAQ:LUMO)
$2.9813
0.3213[12.08%]
At close: Mar 12
$2.9813
0[0.00%]
After Hours: 4:55PM EDT

GET A REPORT ON LUMO SENT RIGHT TO YOUR INBOX

50%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
40
0100
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Dec 23
2
Mar
2
Strong Buy
Buy
Hold
Sell
Strong Sell
About Lumos Pharma Inc
Sector
Health Care
Industry
Biotechnology
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare disease...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LUMO
GLTO

FAQ

Q

How do I buy Lumos Pharma (LUMO) stock?

A

You can purchase shares of Lumos Pharma (NASDAQ: LUMO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lumos Pharma's (LUMO) competitors?

Q

What is the target price for Lumos Pharma (LUMO) stock?

A

The latest price target for Lumos Pharma (NASDAQ: LUMO) was reported by Oppenheimer on Friday, March 8, 2024. The analyst firm set a price target for 16.00 expecting LUMO to rise to within 12 months (a possible 436.68% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lumos Pharma (LUMO)?

A

The stock price for Lumos Pharma (NASDAQ: LUMO) is $2.9813 last updated March 12, 2024 at 4:55 PM EDT.

Q

Does Lumos Pharma (LUMO) pay a dividend?

A

There are no upcoming dividends for Lumos Pharma.

Q

When is Lumos Pharma (NASDAQ:LUMO) reporting earnings?

A

Lumos Pharma’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Q

Is Lumos Pharma (LUMO) going to split?

A

There is no upcoming split for Lumos Pharma.

Q

What sector and industry does Lumos Pharma (LUMO) operate in?

A

Lumos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch